Literature DB >> 6205770

Histamine-releasing activity. IV. Molecular heterogeneity of the activity from stimulated human thoracic duct lymphocytes.

M A Lett-Brown, D O Thueson, D E Plank, M P Langford, J A Grant.   

Abstract

Previous studies with the lymphokine, histamine-releasing activity (HRA), showed that HRA consisted of a heterogeneous group of molecules. The possibility of using thoracic duct lymphocytes (TDL) as a source of large quantities of HRA has been investigated. Antigen-stimulated TDL synthesize and release HRA in quantities similar to an equivalent number of peripheral blood lymphocytes (PBL). Streptokinase (SK) antigen routinely caused TDL to produce HRA approximately 15,000 Da. In contrast, staphylococcus enterotoxin B (SEB) induced the formation of a heterogeneous mixture of HRAs with apparent molecular weights of 50,000 and 15,000. Two peaks of activity (HRA I and II) were recovered when the supernatant from SK-stimulated TDL was subjected to ion-exchange chromatography. Interestingly, basophil chemotactic activity (BCA) was also eluted in these two peaks. Although interferon (IFN) is also released by antigen-stimulated TDL, the nonidentity of IFN and HRA was established by fundamental differences in chromatographic properties and specific antisera to IFN. In contrast, these studies suggest that HRA and BCA may be present on the same molecular entity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205770     DOI: 10.1016/0008-8749(84)90012-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  6 in total

Review 1.  IgE-dependent histamine-releasing factors.

Authors:  H A Sampson; S M MacDonald
Journal:  Springer Semin Immunopathol       Date:  1993

2.  Bacterial antigens stimulate the production of histamine releasing factor (HRF) by lymphocytes from intrinsic asthmatic patients.

Authors:  R Alam; P Kuna; J Rozniecki; B Kuzminska
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

3.  Identification of a histamine release inhibitory factor produced by human mononuclear cells in vitro.

Authors:  R Alam; J A Grant; M A Lett-Brown
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Interleukin 3 activates human blood basophils via high-affinity binding sites.

Authors:  P Valent; J Besemer; M Muhm; O Majdic; K Lechner; P Bettelheim
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

Review 5.  Histamine-releasing factors and heterogeneity of IgE.

Authors:  S M MacDonald; L M Lichtenstein
Journal:  Springer Semin Immunopathol       Date:  1990

6.  Interleukin 3-dependent mediator release in basophils triggered by C5a.

Authors:  Y Kurimoto; A L de Weck; C A Dahinden
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.